<h4>Background</h4>Plasma phosphorylated tau at threonine 217 (p-Tau217) has emerged as a highly sensitive and specific blood-based biomarker for Alzheimer's Disease (AD). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.